TrialDiabetes care2015

Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study.

Jay S Skyler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.